South San Fransisco


REG™ is commercializing industrial biotechnology processes that provide cost-competitive, renewable alternatives to petroleum-based chemicals, fuels, and other products to our customers.  At the core of our technology are biological catalysts engineered to selectively convert abundant, renewable feedstocks directly to drop-in, advantaged and innovative products. REG™ services include working with partners to provide research and development for new product platforms.

Learn more about our products

REG Life Sciences™

Industry-leading research

  • REG Life Sciences™ services include a proprietary method for the synthesis of mid-to-long chain (8 to 18 carbon) chemicals; developed in our R&D laboratories in South San Francisco, California
  • Demonstrated expertise with biotechnology tools to optimize molecular composition to customer needs -- for instance, multi-functional chemicals with tailored positioned hydroxyl groups
  • Patented process covers the catalytic capabilities of microbial metabolism to produce targeted final products in an environmentally friendly fermentation process

Production capacity

  • REG Life Sciences™ services include a demonstration-scale fermentation facility located in Florida with capacity for modifying more than 200 tons/year
  • Proprietary technology enables the production of multiple products in our fermentation facility

Diverse feedstock, low-GHG impact

  • The REG platform technology can use a variety of feedstocks to produce low-GHG performance molecules and replacements for palm-sourced oleochemicals
  • Our process allows us to use low-cost feedstocks to produce sustainable, competively-priced REG chemicals.  Calculated low-carbon impact of glycerol feedstock for detergent alcohols is 85 percent lower than incumbent products

Innovate with REG Life Sciences™ Manufacturing Services and R&D Services.

Get creative.  Design your next innovative compound with REG Life Sciences.
Explore the capabilities of our biochemical platform by emailing us directly at

Catalyst Platform

picture of proprietary
  • Proprietary "​oleaginous" E. coli

  • Optimized strains: product titers of 150 g/L +​

Bio-Chemical Platform

picture of proprietary
  • Combinatorial biochemical pathways to ~15,000 potential products

  • ​Fragrances & flavors, C8/C10 platform, polymer, precursors, novel intermediates

Process Platform

picture of proprietary
  • ​Biphasic fermentation facilitates separation

  • ​Greater than 100MT capacity facility​

Feedstock Flexibility

picture of proprietary
  • Lower-cost glycerol, sugars, and carbohydrates

  • Lower lifecycle-GHG compared to conventional chemicals

World-Class Partnerships

Footer Border